The Role of CXCL16 in the Pathogenesis of Cancer and Other Diseases.

The Role of CXCL16 in the Pathogenesis of Cancer and Other Diseases.
复制标题

DOI:
10.3390/ijms22073490
复制
发表时间:
2021-03-28
影响因子:
5.6
通讯作者:
Baranowska-Bosiacka I
Baranowska-Bosiacka I
中科院分区:
生物学2区
文献类型:
--
作者:
Korbecki J;Bajdak-Rusinek K;Kupnicka P;Kapczuk P;Simińska D;Chlubek D;Baranowska-Bosiacka I

文献摘要

参考文献

被引文献

相似文献

CXCL16是一种趋化细胞因子,属于α趋化因子亚家族。它在癌症的进展以及动脉粥样硬化、肾纤维化和非酒精性脂肪性肝病(NAFLD)的病程中起着重要的作用。由于目前还没有综述文章讨论这种趋化因子在各种疾病中的重要性,我们在这篇综述中收集了关于CXCL16的所有现有知识。在论文的第一部分,我们讨论了CXCL16及其受体CXCR6的背景信息。接下来,我们关注CXCL16在多种疾病中的重要性,重点是癌症。我们讨论了CXCL16在肿瘤细胞增殖、迁移、侵袭和转移中的作用。接下来,我们描述了CXCL16在肿瘤微环境中的作用,包括参与血管生成,以及它在肿瘤相关细胞(肿瘤相关成纤维细胞(CAF)、小胶质细胞、肿瘤相关巨噬细胞()、肿瘤相关中性粒细胞(TAN)、间充质干细胞(MSC)、髓系抑制细胞(MDSC)和调节性T细胞(Treg))中的意义。最后,我们重点研究了主要由自然杀伤T细胞(NKT)引起的CXCL16的抗肿瘤作用。文章最后总结了CXCL16在肿瘤治疗中的重要作用。
CXCL16 is a chemotactic cytokine belonging to the α-chemokine subfamily. It plays a significant role in the progression of cancer, as well as the course of atherosclerosis, renal fibrosis, and non-alcoholic fatty liver disease (NAFLD). Since there has been no review paper discussing the importance of this chemokine in various diseases, we have collected all available knowledge about CXCL16 in this review. In the first part of the paper, we discuss background information about CXCL16 and its receptor, CXCR6. Next, we focus on the importance of CXCL16 in a variety of diseases, with an emphasis on cancer. We discuss the role of CXCL16 in tumor cell proliferation, migration, invasion, and metastasis. Next, we describe the role of CXCL16 in the tumor microenvironment, including involvement in angiogenesis, and its significance in tumor-associated cells (cancer associated fibroblasts (CAF), microglia, tumor-associated macrophages (TAM), tumor-associated neutrophils (TAN), mesenchymal stem cells (MSC), myeloid suppressor cells (MDSC), and regulatory T cells (Treg)). Finally, we focus on the antitumor properties of CXCL16, which are mainly caused by natural killer T (NKT) cells. At the end of the article, we summarize the importance of CXCL16 in cancer therapy.
DOI: 10.1002/stem.1614
发表时间: 2014-05-01
期刊: STEM CELLS
影响因子: 5.2
作者:
Behnan, Jinan;Isakson, Pauline;Badn, Wiaam
通讯作者: Badn, Wiaam
DOI: 10.4049/jimmunol.172.10.6362
发表时间: 2004-05-15
影响因子: 4.4
作者:
Abel, S;Hundhausen, C;Ludwig, A
通讯作者: Ludwig, A
DOI: 10.1074/jbc.m311660200
发表时间: 2004-01-30
影响因子: 4.8
作者:
Chandrasekar, B;Bysani, S;Mummidi, S
通讯作者: Mummidi, S
DOI: 10.1161/circulationaha.105.540583
发表时间: 2006-08-08
期刊: CIRCULATION
影响因子: 37.8
作者:
Aslanian, Ara M.;Charo, Israel F.
通讯作者: Charo, Israel F.
DOI: 10.1371/journal.pone.0006695
发表时间: 2009-08-19
期刊: PloS one
影响因子: 3.7
作者:
Darash-Yahana M;Gillespie JW;Hewitt SM;Chen YY;Maeda S;Stein I;Singh SP;Bedolla RB;Peled A;Troyer DA;Pikarsky E;Karin M;Farber JM
通讯作者: Farber JM